SindhuNairMD

Breast Cancer

Houston Methodist Oncology Partners Sugar Land

Telehealth Available

Overview of Dr. Nair

Dr. Sindhu Nair is an oncologist in Sugar Land, TX and is affiliated with multiple hospitals in the area, including Houston Methodist Sugar Land Hospital, Houston Methodist West Hospital, and Houston Methodist Hospital. She received her medical degree from Baylor College of Medicine and has been in practice 13 years. She specializes in hematologic oncology and is experienced in thoracic cancer, gastrointestinal cancer, colorectal cancer, hematologic oncology, breast cancer, gynecologic cancers and cancer genetics. She also specializes in benign hematology.

Office
16659 Southwest Freeway
Suite 131
Sugar Land, TX 77479
Book by Phone+1(346) 591-8068

Fax+1 281-276-5201

Education & Training

Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
Baylor College of MedicineResidency, Internal Medicine, 2004 - 2007
Baylor College of MedicineClass of 2004

Certifications & Licensure

TX State Medical License 2009 - 2027
PA State Medical License 2008 - 2010
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer Start of enrollment: 2019 Apr 05
ACTIVE_NOT_RECRUITING
PHASE3
A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer) Start of enrollment: 2022 Aug 03
ACTIVE_NOT_RECRUITING
PHASE3

Publications & Presentations

PubMed

11 citations
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer.
Kai Sun, Yitian Xu, Licheng Zhang, Polly Niravath, Jorge Darcourt
Clinical Cancer Research. 2022-10-14
5 citations
ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer
Emre Koca, Polly A. Niravath, Joe Ensor, Tejal Patel, Xiaoxian Li
Breast Cancer Research and Treatment. 2021-04-15

Press Mentions

Beat the Pack’ Program to Help People Quit Smoking Offered at Houston Methodist Sugar Land HospitalNovember 14th, 2019
Colorectal Cancer Seminar Fighting Rare, Genetic Colorectal CancerFebruary 2nd, 2017